Skip to main content

Table 4 Response to treatment related to sCD73 enzyme activity levels

From: Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab

  sCD73 < 27.8 pmol/min/mg protein sCD73 > 27.8 pmol/min/mg protein Pts
CR 0
PR 9 (100%) 0 9
SD 8 (100%) 0 8
PD 9 (52.9%) 8 (47.1%) 17
DCR
(CR + PR + SD)
17 (100%) 0 17
  1. Pts patients, CR complete response, PR partial response, SD stable disease, PD progressive disease, DCR disease control rate